FACING NOVEL COVID-19 CHALLENGES: AIR MONITORING IN CONFINED, CLOSED AREAS.
24 06 2020
CellMade, a biopharmaceutical developing biomarkers and diagnostic tools for widespread diseases such as obesity, non-alcoholic fatty liver disease, type II diabetes, cardiovascular and respiratory diseases launches a comprehensive range of products for environmental COVID-19 testing using rRT-PCR methods.
Collecting air in confined areas will assist decision makers in monitoring of risks related to the potential spreading of SARS-CoV-2. This is especially true now governments around the world enter into novel phases of lifting containment measures!